Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Acies Bio is a leading European microbial biotechnology company that specializes in the development of innovative technologies for the pharmaceutical, food, and agricultural industries. The company leverages its proprietary SmartFermentation platform and advanced synthetic biology tools to optimize microbial strains and bioprocesses for the production of high-value natural products and recombinant proteins. Acies Bio provides a comprehensive suite of services, including strain engineering, bioprocess development, and pilot-scale manufacturing, while also maintaining an internal pipeline of sustainable bio-based products. Their notable 'One-Carbon' (C1) technology platform focuses on converting methanol into valuable chemicals, positioning the company at the forefront of sustainable industrial biotechnology.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on ACIES.